Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Assessment of therapeutic response and treatment planning for brain tumors using metabolic and physiological MRI.

Nelson SJ.

NMR Biomed. 2011 Jul;24(6):734-49. doi: 10.1002/nbm.1669. Epub 2011 Apr 27. Review.

2.

Integration of preoperative anatomic and metabolic physiologic imaging of newly diagnosed glioma.

Chang SM, Nelson S, Vandenberg S, Cha S, Prados M, Butowski N, McDermott M, Parsa AT, Aghi M, Clarke J, Berger M.

J Neurooncol. 2009 May;92(3):401-15. doi: 10.1007/s11060-009-9845-0. Epub 2009 Apr 9.

3.

Diffusion-weighted and perfusion MR imaging for brain tumor characterization and assessment of treatment response.

Provenzale JM, Mukundan S, Barboriak DP.

Radiology. 2006 Jun;239(3):632-49. Review.

PMID:
16714455
4.

Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.

Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J, Dillon W, Warach S, Broderick J, Tilley B, Sacks D; Technology Assessment Committee of the American Society of Interventional and Therapeutic Neuroradiology; Technology Assessment Committee of the Society of Interventional Radiology.

Stroke. 2003 Aug;34(8):e109-37. Epub 2003 Jul 17. Erratum in: Stroke. 2003 Nov;34(11):2774.

5.
6.

Imaging glioblastoma multiforme.

Nelson SJ, Cha S.

Cancer J. 2003 Mar-Apr;9(2):134-45. Review.

PMID:
12784879
7.

Metabolic mapping of gliomas using hybrid MR-PET imaging: feasibility of the method and spatial distribution of metabolic changes.

Bisdas S, Ritz R, Bender B, Braun C, Pfannenberg C, Reimold M, Naegele T, Ernemann U.

Invest Radiol. 2013 May;48(5):295-301. doi: 10.1097/RLI.0b013e31827188d6.

PMID:
23296081
8.

Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?

Weber MA, Henze M, Tüttenberg J, Stieltjes B, Meissner M, Zimmer F, Burkholder I, Kroll A, Combs SE, Vogt-Schaden M, Giesel FL, Zoubaa S, Haberkorn U, Kauczor HU, Essig M.

Invest Radiol. 2010 Dec;45(12):755-68. doi: 10.1097/RLI.0b013e3181ec9db0.

PMID:
20829706
9.

Validation of neuroradiologic response assessment in gliomas: measurement by RECIST, two-dimensional, computer-assisted tumor area, and computer-assisted tumor volume methods.

Galanis E, Buckner JC, Maurer MJ, Sykora R, Castillo R, Ballman KV, Erickson BJ.

Neuro Oncol. 2006 Apr;8(2):156-65. Epub 2006 Mar 2.

10.

Introduction of a standardized multimodality image protocol for navigation-guided surgery of suspected low-grade gliomas.

Mert A, Kiesel B, Wöhrer A, Martínez-Moreno M, Minchev G, Furtner J, Knosp E, Wolfsberger S, Widhalm G.

Neurosurg Focus. 2015 Jan;38(1):E4. doi: 10.3171/2014.10.FOCUS14597.

PMID:
25552284
11.

Characterization of untreated gliomas by magnetic resonance spectroscopic imaging.

Nelson SJ, McKnight TR, Henry RG.

Neuroimaging Clin N Am. 2002 Nov;12(4):599-613. Review.

PMID:
12687914
12.

Differentiating surgical from non-surgical lesions using perfusion MR imaging and proton MR spectroscopic imaging.

Law M, Hamburger M, Johnson G, Inglese M, Londono A, Golfinos J, Zagzag D, Knopp EA.

Technol Cancer Res Treat. 2004 Dec;3(6):557-65. Review.

PMID:
15560713
13.

Diffusion-weighted MR imaging for the differentiation of true progression from pseudoprogression following concomitant radiotherapy with temozolomide in patients with newly diagnosed high-grade gliomas.

Lee WJ, Choi SH, Park CK, Yi KS, Kim TM, Lee SH, Kim JH, Sohn CH, Park SH, Kim IH.

Acad Radiol. 2012 Nov;19(11):1353-61. doi: 10.1016/j.acra.2012.06.011. Epub 2012 Aug 11.

PMID:
22884399
14.

Advanced MRI of adult brain tumors.

Young GS.

Neurol Clin. 2007 Nov;25(4):947-73, viii. Review.

PMID:
17964022
15.

[Use of amino acid PET in the Diagnostic and Treatment Management of cerebral gliomas].

Galldiks N, Langen KJ.

Fortschr Neurol Psychiatr. 2012 Jan;80(1):17-23. doi: 10.1055/s-0031-1281851. Epub 2011 Dec 12. Review. German.

PMID:
22161228
16.

High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging.

Law M, Cha S, Knopp EA, Johnson G, Arnett J, Litt AW.

Radiology. 2002 Mar;222(3):715-21.

PMID:
11867790
17.

Focal changes in diffusivity on apparent diffusion coefficient MR imaging and amino acid uptake on PET do not colocalize in nonenhancing low-grade gliomas.

Rahm V, Boxheimer L, Bruehlmeier M, Berberat J, Nitzsche EU, Remonda L, Roelcke U.

J Nucl Med. 2014 Apr;55(4):546-50. doi: 10.2967/jnumed.113.130732. Epub 2014 Feb 24.

18.

Magnetic resonance spectroscopic imaging for visualization of the infiltration zone of glioma.

Stadlbauer A, Buchfelder M, Doelken MT, Hammen T, Ganslandt O.

Cent Eur Neurosurg. 2011 May;72(2):63-9. doi: 10.1055/s-0030-1253410. Epub 2010 Jul 15.

PMID:
20635312
19.

3D MRSI for resected high-grade gliomas before RT: tumor extent according to metabolic activity in relation to MRI.

Pirzkall A, Li X, Oh J, Chang S, Berger MS, Larson DA, Verhey LJ, Dillon WP, Nelson SJ.

Int J Radiat Oncol Biol Phys. 2004 May 1;59(1):126-37.

PMID:
15093908
20.

Supplemental Content

Support Center